Abstract View

Author(s): Kartikay Prakash*11, Dr. Shashank Tiwari22, Preet Patel33, Kirti Singh34

Email(s): 1kartikrajpoot80@gmail.com

Address:

    1. Assistant Professor, Department of Pharmacy, Khwaja Moinuddin Chishti Language University, Lucknow, Uttar Pradesh, Bharat. 2. Director (Academic and Research), Department of Pharmacy, Lucknow Model College of Pharmacy, Lucknow, 226008, Uttar Pradesh, Bharat. 3.B. Pharm, Lucknow Model College of Pharmacy, Lucknow, 226008, Uttar Pradesh, Bharat.

Published In:   Volume - 4,      Issue - 2,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.4207  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
This review aims to provide a comprehensive virology and pathogenesis of HIV, the epidemiological landscape, challenges in diagnosis and treatment, Herbal Treatment, FDA approved Novel Drug for the Treatment of HIV and the socio-behavioral aspects affecting prevention and care, and promising directions in research, including vaccine development and potential eradication strategies. By consolidating insights from diverse fields, this review intends to contribute to a deeper understanding of HIV and its multifaceted impacts, aiming to inform future directions for research, policy, and public health interventions.

Cite this article:
Kartikay Prakash, Dr. Shashank Tiwari, Preet Patel, Kirti Singh.Comprehensive Review On HIV: History, Challenges, Treatments, And Emerging Research Trends.IJRPAS, Feb 2025; 4 (2): 74-89.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4207


1.        Vivancos MJ, Martínez-Sanz J, Guillén SM. HIV infection epidemiology: a change of scenery. Eur Geriatr Med. 2018 Dec 11. https://doi.org/10.1007/s41999-018-0147-y.

2.        Bachani D, Sogarwal R. National response to HIV/AIDS in India. Indian J Community Med. 2010 Oct;35(4):469-72. doi: 10.4103/0970-0218.74341.

3.        H. A Timeline of HIV and AIDS. HIV.gov. 2023 Nov 15. https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline.

4.        Global HIV/AIDS Timeline. KFF. 2019 Apr 19. https://www.kff.org/global-health-policy/timeline/global-hivaids-timeline/.

5.        Timeline of HIV/AIDS. Wikipedia. 2023 Dec 15. https://en.wikipedia.org/wiki/Timeline_of_HIV/AIDS.

6.        HIV Facts & Figures | National AIDS Control Organization | MoHFW | GoI. [cited 2023 Mar 3]. https://naco.gov.in/hiv-facts-figures.

7.        The AIDS Epidemic in the United States, 1981-early 1990s. CDC Museum. [cited 2023 Mar 3]. https://www.cdc.gov/museum/online/story-of-cdc/aids/index.html.

8.        Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, Aouizerat BE. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Symptom Manage. 2009 Dec;38(6):882-93. doi: 10.1016/j.jpainsymman.2009.05.013.

9.        Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanita. 2010 Jan 1;46(1):3-10. https://doi.org/10.4415/ann_10_01_02.

10.    Naif HM. Pathogenesis of HIV infection. Infect Dis Rep. 2013 Jun 6;5(11):e6. https://doi.org/10.4081/idr.2013.s1.e6.

11.    Rabson AB. HIV virology: Implications for the pathogenesis of HIV infection. J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1159-61. https://doi.org/10.1016/0190-9622(90)70162-b.

12.    Salgado M, Garcia-Minambres A, Dalmau J, Jiménez-Moyano E, Viciana P, Alejos B, et al. Control of HIV-1 pathogenesis in viremic nonprogressors is independent of gag-specific cytotoxic T lymphocyte responses. J Virol. 2018 Jun 15;92(12). https://doi.org/10.1128/jvi.00346-18.

13.    National Research Council (US) Panel on Data and Research Priorities for Arresting AIDS in Sub-Saharan Africa. Preventing and mitigating AIDS in Sub-Saharan Africa: research and data priorities for the social and behavioral sciences. Washington (DC): National Academies Press (US); 1996. Available from: https://www.ncbi.nlm.nih.gov/books/NBK232813/.

14.    Pandve HT, Giri PA. HIV/AIDS prevention and control in India: achievements and future challenges. N Am J Med Sci. 2015 Dec;7(12):575-6. doi: 10.4103/1947-2714.172853.

15.    Kumar P, Das C, Kumar A, Sahu D, Rai SK, Godbole S, et al. Diversity in HIV epidemic transitions in India: An application of HIV epidemiological metrics and benchmarks. PLoS One. 2022 Jul 18;17(7):e0270886. doi: 10.1371/journal.pone.0270886.

16.    Vivancos MJ, Martínez-Sanz J, Moreno S. HIV infection epidemiology: a change of scenery. Eur Geriatr Med. 2019 Jun 15;10(3):169-74. https://doi.org/10.1007/s41999-018-0147-y.

17.    India to provide HIV treatment to all who need it. UNAIDS. [cited 2023 Mar 3]. https://www.unaids.org/en/resources/presscentre/featurestories/2017/may/20170501_veena.

18.    India HIV Estimates 2021. National AIDS Control Organization. [cited 2023 Mar 3]. https://naco.gov.in/sites/default/files/India%20HIV%20Estimates%202021%20_Fact%20Sheets__Final_Shared_24_08_2022.pdf.

19.    ART Treatment | National AIDS Control Organization | MoHFW | GoI. [cited 2023 Mar 3]. https://naco.gov.in/treatment.

20.    India to provide HIV treatment to all who need it. UNAIDS. [cited 2023 Mar 3]. https://www.unaids.org/en/resources/presscentre/featurestories/2017/may/20170501_veena.

21.    NACP V Strategy Booklet. National AIDS Control Organization. [cited 2023 Mar 3]. https://naco.gov.in/sites/default/files/NACP_V_Strategy_Booklet.pdf.

22.    Batra E. India’s pivotal role in the global fight against AIDS: Revolutionising HIV treatment with low-cost antiretrovirals. CNBCTV18. 2023 Jul 18. https://www.cnbctv18.com/healthcare/aids-india-pivotal-role-global-fight-hiv-treatment-low-cost-arv-drugs-anti-retroviral-therapy-17247721.html.

23.    Carbonero-Lechuga P, Castrodeza-Sanz J, Sanz-Muñoz I, Marqués-Sánchez P, Eiros JM, Dueñas-Gutiérrez C, et al. Impact of COVID-19 on adherence to treatment in patients with HIV. Healthcare (Basel). 2023 May 2;11(9):1299. doi: 10.3390/healthcare11091299.

24.    Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: a call to action. Int J Environ Res Public Health. 2020 Jun 24;17(12):4548. doi: 10.3390/ijerph17124548.

25.    COVID-19’s impact on HIV treatment less severe than feared. UNAIDS. [cited 2023 Mar 3]. https://www.unaids.org/en/resources/presscentre/featurestories/2020/october/20201016_covid-impact-on-hiv-treatment-less-severe-than-feared.

26.    SeyedAlinaghi S, Mirzapour P, Pashaei Z, et al. The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review. AIDS Res Ther. 2023 Jan 20;20(1):4. https://doi.org/10.1186/s12981-022-00496-7.

27.    H. COVID-19 and People with HIV. HIV.gov. 2023 Oct 12. https://www.hiv.gov/hiv-basics/staying-in-hiv-care/other-related-health-issues/coronavirus-covid-19.

28.    Klein WM, Bloch M, Hesse BW, McDonald PG, Nebeling L, O'Connell ME, et al. Behavioral research in cancer prevention and control: a look to the future. Am J Prev Med. 2014 Mar;46(3):303-11. doi: 10.1016/j.amepre.2013.10.004.

29.    Improving People’s Health: Behavioral Strategy. [cited 2023 Mar 3]. https://assets.publishing.service.gov.uk/media/5bb21dd2e5274a3e0d7af9e0/Improving_Peoples_Health_Behavioural_Strategy.pdf.

30.    Hogben M, Dittus PJ, Leichliter JS, Aral SO. Social and behavioural research prospects for sexually transmissible infection prevention in the era of advances in biomedical approaches. Sex Health. 2020 Apr;17(2):103-13. doi: 10.1071/SH19105.

31.    Valente PK, Wu Y, Cohen YZ, Caskey M, Meyers K. Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention. Clin Trials. 2021;18(1):17-27. doi: 10.1177/1740774520948042.

32.    Salehi B, Kumar NVA, Şener B, Sharifi-Rad M, Kılıç M, Mahady GB, et al. Medicinal plants used in the treatment of human immunodeficiency virus. Int J Mol Sci. 2018 May 14;19(5):1459. doi: 10.3390/ijms19051459.

33.    HIV Medicines. [cited 2023 Mar 3]. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines.

34.    CNN. HIV vaccine trial halted. [cited 2023 Dec 9]. https://edition.cnn.com/2023/12/09/health/hiv-vaccine-trial-halted-intl/index.html.

35.    Misconceptions about HIV/AIDS. Wikipedia. 2023 Nov 7. https://en.wikipedia.org/wiki/Misconceptions_about_HIV/AIDS.

36.    Common Misconceptions about AIDS. Narayana Health Care. 2019 Dec 24. https://www.narayanahealth.org/blog/common-misconceptions-about-aids/amp/.

37.    7 Common Misconceptions About HIV. Ending HIV. 2023 Dec 7. https://endinghiv.org.au/blog/7-common-misconceptions-hiv/.

38.    Crna RNM. HIV and AIDS: Transmission myths and facts. Medical News Today. 2023 Oct 6. https://www.medicalnewstoday.com/articles/323832.

39.    Schaefer A. 9 Myths About HIV/AIDS. Healthline. 2020 Apr 24. https://www.healthline.com/health/hiv-aids/misconceptions-about-hiv-aids.

 

 

Related Images:



Recent Images



A Review on Diabetes Mellitus: Type1 & Type2
Formulation and Evaluation of Herbal Hair Mask
FT-IR and UV-Vis Spectroscopic studies of Cd(II), Hg(II) and Zn(II)  metal complexes of 2-methoxy-2
FT-IR and UV-Vis Spectroscopic studies of Co(II), Cu(II) and Mn(II) metal complexes of 2-methoxy-2
Simultaneous UV Spectrophotometric Analysis of Paracetamol and Ibuprofen in an Ethanol–NaoH Solvent System
A Review on Antiseptic Gargle
Formulation and Characterisation of Papaya Leaf Gel
Formulation and Characterisation of Herbal Neem Soap
Formulation and Evaluation of Herbal Hair Serum
Pharmaceutical Marketing Role to Adapt Drug Promotional Practices at the duration times  of Pandemic Covid-19

Tags


Recomonded Articles:

Author(s): Nikita Girnare; Sameera Kara; Krishnarati Patil; Rajeshree Padvi

DOI:         Access: Open Access Read More

Author(s): Jayesh M. Rajput

DOI:         Access: Open Access Read More

Author(s): Kartikay Prakash*1; Dr. Shashank Tiwari2; Preet Patel3; Kirti Singh3

DOI: https://doi.org/10.71431/IJRPAS.2025.4207         Access: Open Access Read More